Allison C. Hoffman Sells 1,245 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) General Counsel Allison C. Hoffman sold 1,245 shares of the stock in a transaction that occurred on Thursday, July 17th. The stock was sold at an average price of $26.89, for a total transaction of $33,478.05. Following the completion of the sale, the general counsel owned 136,978 shares of the company's stock, valued at approximately $3,683,338.42. The trade was a 0.90% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Phreesia Stock Performance

PHR stock traded down $0.61 during midday trading on Thursday, hitting $27.09. 420,413 shares of the company traded hands, compared to its average volume of 577,443. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.02. The business has a 50 day simple moving average of $26.58 and a 200-day simple moving average of $26.43. The stock has a market capitalization of $1.61 billion, a price-to-earnings ratio of -36.60 and a beta of 0.72.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The business had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. During the same period in the prior year, the firm earned ($0.05) EPS. Phreesia's quarterly revenue was up 14.5% compared to the same quarter last year. As a group, equities research analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analysts Set New Price Targets

PHR has been the topic of a number of recent research reports. KeyCorp boosted their target price on Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a research note on Monday, July 14th. Citigroup reiterated a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Canaccord Genuity Group dropped their price objective on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a report on Thursday, May 29th. DA Davidson upgraded shares of Phreesia to a "strong-buy" rating in a research note on Tuesday. Finally, Truist Financial boosted their target price on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Eleven research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Phreesia currently has an average rating of "Buy" and a consensus price target of $32.27.

Institutional Investors Weigh In On Phreesia

A number of hedge funds have recently bought and sold shares of PHR. Invesco Ltd. boosted its position in shares of Phreesia by 0.9% in the fourth quarter. Invesco Ltd. now owns 40,249 shares of the company's stock valued at $1,013,000 after acquiring an additional 357 shares during the period. Diversified Trust Co boosted its holdings in Phreesia by 1.0% in the 2nd quarter. Diversified Trust Co now owns 45,042 shares of the company's stock valued at $1,282,000 after purchasing an additional 426 shares during the period. NewEdge Advisors LLC grew its position in Phreesia by 12.1% in the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock worth $107,000 after purchasing an additional 459 shares during the last quarter. Arcadia Investment Management Corp MI grew its position in Phreesia by 0.7% in the 1st quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company's stock worth $2,371,000 after purchasing an additional 615 shares during the last quarter. Finally, QRG Capital Management Inc. increased its holdings in shares of Phreesia by 8.0% during the 1st quarter. QRG Capital Management Inc. now owns 11,118 shares of the company's stock worth $284,000 after purchasing an additional 827 shares during the period. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.